机译:检查内分泌的成本效益早期乳腺癌的治疗方法:的影响不同建模方法的结果
Department of Clinical Pharmacology and Experimental Therapy, Netherlands Cancer Institute;
Department of Health Policy and Management, Erasmus University, Rotterdam, Netherlands;
GlaxoSmithKline, Zeist, NetherlandsGlaxoSmithKline, Zeist, Netherlands, Science Faculty, Department of Pharmaceutical Sciences;
therapy, endocrine; Breast Cancer; Cost EffectivenessMarkovModel LawsAdverse Event Associated with the Endocrine SystemEconomic EvaluationQuality-Adjusted Life Yearsanastrozolecancer therapy;
机译:Cost-effectiveness of endocrine therapy versus radiotherapy versus combined endocrine and radiotherapy for older women with early-stage breast cancer
机译:An evidence-based review of the outcome of fulvestrant plus a targeted agent versus fulvestrant alone in treating hormone receptor-positive endocrine therapy-resistant metastatic breast cancer
机译:Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older
机译:should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? preclinical modeling in ovarian cancer